Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology
Atherosclerosis is a common metabolic disease characterized by lipid metabolic disorder. The processes of atherosclerosis include endothelial dysfunction, new endothelial layer formation, lipid sediment, foam cell formation, plaque formation, and plaque burst. Owing to the adverse effects of first-l...
Main Authors: | Xuejiao Xie, Xingyu Ma, Siyu Zeng, Wansi Tang, Liucheng Xiao, Chenggong Zhu, Rong Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/3568756 |
Similar Items
-
Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
by: Shengjie Yang, et al.
Published: (2021-07-01) -
Mechanisms of saffron in treatment of atherosclerosis based on network pharmacology
by: Jing Yang, et al.
Published: (2021-06-01) -
Pharmacokinetics and Pharmacological Activities of Berberine in Diabetes Mellitus Treatment
by: Yunfeng Han, et al.
Published: (2021-01-01) -
Systematic Investigation of Berberine for Treating Hepatocellular Carcinoma Based on Network Pharmacology
by: Mu Jie, et al.
Published: (2019-09-01) -
Mechanism and pharmacological rescue of berberine-induced hERG channel deficiency
by: Yan M, et al.
Published: (2015-10-01)